Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site.

Synergistic neutralization of human immunodeficiency virus type 1 (HIV-1) was observed in studies using a chimpanzee anti-V2 monoclonal antibody (MAb), C108G, in combination with anti-V3 loop and anti-CD4 binding-site (bs) MAbs of different epitope specificities. C108G paired with either of two anti...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Vijh-Warrier, S, Pinter, A, Honnen, W J, Tilley, S A
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1996
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190381/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8676471/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.70.7.4466-4473.1996
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!